Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.75B | $10.68B | $11.44B | $11.46B | $11.30B | $11.02B | $10.56B | $10.32B |
| Cost of revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B |
| Gross profit | $1.31B | $1.41B | $1.31B | $1.41B | $1.47B | $1.54B | $1.56B | $1.68B |
| Gross margin | 12.2% | 13.2% | 11.4% | 12.3% | 13.0% | 14.0% | 14.8% | 16.3% |
| Selling, general and administrative | $724.00M | $779.00M | $795.00M | $729.00M | $711.00M | $774.00M | $665.00M | $676.00M |
| Operating expenses | $1.29B | $1.44B | $1.47B | $1.28B | $1.23B | $1.24B | $1.20B | $1.23B |
| Operating income | $20.00M | −$37.00M | −$161.00M | $131.00M | $245.00M | $302.00M | $363.00M | $446.00M |
| Operating margin | 0.2% | -0.3% | -1.4% | 1.1% | 2.2% | 2.7% | 3.4% | 4.3% |
| EBITDA | $60.00M | $95.00M | −$117.00M | $176.00M | $303.00M | $350.00M | $411.00M | $493.00M |
| Interest income | $101.00M | $98.00M | $0 | — | $106.00M | $108.00M | $0 | — |
| Interest expense | −$54.00M | −$54.00M | −$52.00M | −$49.00M | −$48.00M | −$43.00M | −$34.00M | −$29.00M |
| Income before taxes | $91.00M | $29.00M | −$214.00M | $88.00M | $325.00M | $390.00M | $346.00M | $438.00M |
| Income taxes | $31.00M | $15.00M | −$54.00M | $9.00M | $70.00M | $92.00M | $95.00M | $112.00M |
| Net income | $60.00M | $14.00M | −$160.00M | $79.00M | $255.00M | $298.00M | $251.00M | $326.00M |
| Net margin | 0.6% | 0.1% | -1.4% | 0.7% | 2.3% | 2.7% | 2.4% | 3.2% |
| EPS, basic | $1.19 | $0.27 | −$3.17 | $1.51 | $4.75 | $5.47 | $4.48 | $5.67 |
| EPS, diluted | $1.19 | $0.27 | −$3.16 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 |
| Diluted shares | 51.30M | 51.00M | 50.60M | 52.50M | 53.70M | 54.80M | 56.60M | 57.70M |
Figures describe Molina Healthcare, Inc. shares, not any token. As of Jul 23, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.